BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12496476)

  • 1. A naturally occurring allele of BRCA1 coding for a temperature-sensitive mutant protein.
    Worley T; Vallon-Christersson J; Billack B; Borg A; Monteiro AN
    Cancer Biol Ther; 2002; 1(5):497-501. PubMed ID: 12496476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the BRCT domain confer temperature sensitivity to BRCA1 in transcription activation.
    Carvalho MA; Billack B; Chan E; Worley T; Cayanan C; Monteiro AN
    Cancer Biol Ther; 2002; 1(5):502-8. PubMed ID: 12496477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creating a tool-kit for exploring BRCA1 function.
    Parvin JD
    Cancer Biol Ther; 2002; 1(5):509-10. PubMed ID: 12496478
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for a transcriptional activation function of BRCA1 C-terminal region.
    Monteiro AN; August A; Hanafusa H
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13595-9. PubMed ID: 8942979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential transcriptional activation by the N-terminal region of BRCA1 splice variants BRCA1a and BRCA1b.
    Cui JQ; Wang H; Reddy ES; Rao VN
    Oncol Rep; 1998; 5(3):585-9. PubMed ID: 9538156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional comparison of BRCA1 C-terminal domains in transcription activation and chromatin remodeling.
    Miyake T; Hu YF; Yu DS; Li R
    J Biol Chem; 2000 Dec; 275(51):40169-73. PubMed ID: 11016938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a novel trans-activation domain of BRCA1 that functions in concert with the BRCA1 C-terminal (BRCT) domain.
    Hu YF; Miyake T; Ye Q; Li R
    J Biol Chem; 2000 Dec; 275(52):40910-5. PubMed ID: 11067843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations.
    Ye Q; Hu YF; Zhong H; Nye AC; Belmont AS; Li R
    J Cell Biol; 2001 Dec; 155(6):911-21. PubMed ID: 11739404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional assay for BRCA1: mutagenesis of the COOH-terminal region reveals critical residues for transcription activation.
    Hayes F; Cayanan C; Barillà D; Monteiro AN
    Cancer Res; 2000 May; 60(9):2411-8. PubMed ID: 10811118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis to characterise transactivation domain of BRCA1.
    Yadav LR; Biswal MN; Hosur MV; Kumar NS; Varma AK
    J Biomol Struct Dyn; 2017 Jan; 35(1):1-7. PubMed ID: 26727155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.
    Tischkowitz M; Hamel N; Carvalho MA; Birrane G; Soni A; van Beers EH; Joosse SA; Wong N; Novak D; Quenneville LA; Grist SA; ; Nederlof PM; Goldgar DE; Tavtigian SV; Monteiro AN; Ladias JA; Foulkes WD
    Eur J Hum Genet; 2008 Jul; 16(7):820-32. PubMed ID: 18285836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling.
    Shiozaki EN; Gu L; Yan N; Shi Y
    Mol Cell; 2004 May; 14(3):405-12. PubMed ID: 15125843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.
    Vallon-Christersson J; Cayanan C; Haraldsson K; Loman N; Bergthorsson JT; Brøndum-Nielsen K; Gerdes AM; Møller P; Kristoffersson U; Olsson H; Borg A; Monteiro AN
    Hum Mol Genet; 2001 Feb; 10(4):353-60. PubMed ID: 11157798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BRCA1 C-terminal domain: structure and function.
    Huyton T; Bates PA; Zhang X; Sternberg MJ; Freemont PS
    Mutat Res; 2000 Aug; 460(3-4):319-32. PubMed ID: 10946236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins.
    Bork P; Hofmann K; Bucher P; Neuwald AF; Altschul SF; Koonin EV
    FASEB J; 1997 Jan; 11(1):68-76. PubMed ID: 9034168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of protein folding defects caused by BRCA1-BRCT truncation and missense mutations.
    Williams RS; Chasman DI; Hau DD; Hui B; Lau AY; Glover JN
    J Biol Chem; 2003 Dec; 278(52):53007-16. PubMed ID: 14534301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair.
    Callebaut I; Mornon JP
    FEBS Lett; 1997 Jan; 400(1):25-30. PubMed ID: 9000507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine BRCA1 shows classic responses to genotoxic stress but low in vitro transcriptional activation activity.
    Krum SA; Womack JE; Lane TF
    Oncogene; 2003 Sep; 22(38):6032-44. PubMed ID: 12955082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nine novel conserved motifs in BRCA1 identified by the chicken orthologue.
    Orelli BJ; Logsdon JM; Bishop DK
    Oncogene; 2001 Jul; 20(32):4433-8. PubMed ID: 11466627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Dbf4p BRCA1 C-terminal-like domain required for the response to replication fork arrest in budding yeast.
    Gabrielse C; Miller CT; McConnell KH; DeWard A; Fox CA; Weinreich M
    Genetics; 2006 Jun; 173(2):541-55. PubMed ID: 16547092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.